What is Excepgen?
ExcepGen operates within the dynamic medtech sector, specializing in the development of genetic medicines. Headquartered in San Francisco, California, the company is positioned at the forefront of a rapidly evolving field that promises to revolutionize therapeutic approaches. Its focus on genetic medicines indicates a commitment to addressing complex diseases through advanced biological interventions, leveraging cutting-edge research and development.
How much funding has Excepgen raised?
Excepgen has raised a total of $4M across 1 funding round:
Other Financing Round
$4M
Other Financing Round (2023): $4M with participation from Gravity Fund, RA Capital Management, and Apollo Projects
Key Investors in Excepgen
Gravity Fund
Gravity Fund is a venture capital firm specializing in thesis-driven investments across emerging technologies like Web3, AI, and engineered biology, including CRISPR platforms. They focus on innovative sectors and aim to invest in groundbreaking technological advancements.
RA Capital Management
RA Capital Management is an investment manager focused on public and private healthcare and life science companies, including drug development, medical devices, and diagnostics. They also have an interest in climate and sustainability technologies, aiming to bring innovations from the lab to the clinic.
Apollo Projects
Apollo Projects is a design and construction company that collaborates with major corporations, private businesses, sports organizations, and government entities across various industries. Founded in 2001, they provide services for food processing, dairy, commercial, and industrial sectors.
What's next for Excepgen?
The recent major strategic investment signifies a pivotal moment for ExcepGen, likely enabling the company to accelerate its research pipelines, scale its operations, and potentially expand its therapeutic offerings. This enterprise-level backing suggests confidence from investors in ExcepGen's technology and market potential, positioning the company for significant growth and advancement in the competitive genetic medicine landscape. Future developments may include clinical trial progression, strategic partnerships, and the commercialization of its novel treatments.
See full Excepgen company page
